(ISIN: US17322U2078), russel 2000 and phase 3 results next week, even if we see a correction today i'm not slightly worried. See rankings and related performance below. publicly available sources. The Motley Fool has a disclosure policy. We have 9 different ratings for every stock to help you Then consider taking a position in CTXR stock. Sources: FactSet, Dow Jones, Bonds: Bond quotes are updated in real-time. We use cookies to understand how you use our site and to improve your experience. Stocks: Real-time U.S. stock quotes reflect trades reported through Nasdaq only; comprehensive quotes and volume reflect trading in all markets and are delayed at least 15 minutes. That policy paid off as the stock shot up to a 52-week high of $2.90 on Feb. 22. Read More:Penny Stocks How to Profit Without Getting Scammed. Investment Research, Inc, licensed by Zacks Investment Research, Inc. from ET of the following day. Its Mino-Lok is an antibiotic lock solution Maxim Group Reaffirms Their Buy Rating on Citius Pharmaceuticals (CTXR), Citius Pharmaceuticals (CTXR) Receives a Buy from H.C. Wainwright, Citius Pharmaceuticals engages financial advisor for oncology subsidiary spinoff, Analysts Opinions Are Mixed on These Healthcare Stocks: Arcturus Therapeutics (ARCT), Aadi Bioscience (AADI) and Citius Pharmaceuticals (CTXR). ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating indiv idual securities. Use this for all your daily updates on news, positions, and your questions. Citius Pharmaceuticals, Inc., a specialty pharmaceutical company, develops and commercializes critical care products. Have Watchlists? There are currently no items in this Watchlist. The Style Scores are a complementary set of indicators to use alongside the Zacks Rank. Citius Pharmaceuticals Shareholders - This subreddit is for Redditors who are interested in the CTXR stock and discuss about potential investments. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. Private Data are provided 'as is' for informational purposes only and are not intended for trading purposes. Zacks Rank Education -- Learn more about the Zacks Rank News Corp is a global, diversified media and information services company focused on creating and distributing authoritative and engaging content and other products and services. First off, though, it's important to examine this company's stock. Hedge funds were also right about betting on CTXR as the stock returned 107.3% since the end of Q1 (through 6/18) and outperformed the market. appreciate its future potential. Copyright 2023. Welcome to the CTXR Daily Discussion Thread! $5.00. The company is developing Mino-Lok, an antibiotic lock solution used to treat patients with catheter-related bloodstream infections by salvaging the infected catheter, which is in Phase III clinical trials; Mino-Wrap, a liquifying gel-based wrap for reduction of tissue expander infections following breast reconstructive surgeries; Halo-Lido, a corticosteroid-lidocaine topical formulation that is intended to provide anti-inflammatory and anesthetic relief to persons suffering from hemorrhoids; and NoveCite, a mesenchymal stem cell therapy for the treatment of acute respiratory disease syndrome. . 3 Stocks That Are Poised to Plunge. The average price target represents a 227.87% change from the last price of $1.53. We want to hear from you. Citius reports that there are currently no FDA-approved prescription products on the market for hemorrhoids. That could make this company a pioneer in that niche of care. Let's do some quick math to see if that might be enough to make millions. Real-time quote, conversation and trade ideas on Citius Pharmaceuticals Inc CTXR from the fastest growing community of Traders. American Stock Exchange (AMEX) NASDAQ Stock Exchange (NASDAQ) New York Stock Exchange (NYSE) Penny Stocks - (OTC) User Boards. You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. Login Stay up to date on the latest stock price, chart, news, analysis, fundamentals, trading and investment tools. Citius Pharmaceuticals Confirms No Exposure to Silicon Valley Bank. Zacks Earnings ESP (Expected Surprise Prediction) looks to find companies that have recently seen positive earnings estimate revision activity. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. the Web site, including, but not limited to Information originated by Zacks The average price-to-sales ratio (P/S) for a biotech stock is 8.09. Trading on margin increases the financial risks. Mino-lok has a market value of 1.5B in the US alone. Welcome to the CTXR Daily Discussion Thread! At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. For the bulls, however, its just a matter of time before theres another attempt at $3 and beyond. You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the CTXR quote. To learn more, click here. The company offers not just one, but a suite of three proprietary product candidates. Get this delivered to your inbox, and more info about our products and services. Prospective CTXR stock investors deserve a much more in-depth discussion of this fascinating company. Different scenarios for ML trial. Copyright 2016-2023 Echofin Inc. All rights reserved. We're starting off the day with a breakdown of the biggest pre-market stock movers traders need to know about on Tuesday! In fact, it has already received a Qualified Infectious Disease Product (QIDP) designation from the U.S. Food and Drug Administration (FDA). However, CITI-002 is also particularly promising here. Company Profile CTXR. Stock is jumping up today! Copyright 2023 Zacks Investment Research | 10 S Riverside Plaza Suite #1600 | Chicago, IL 60606. Yet, as the old saying goes, be right and sit tight. Citius Pharmaceuticals, Inc. (CTXR) Company Bio. Currently trading around $1.28/share and analysts suggest $6-$10/share after FDA approval of Mino-Lok Results for phase 3 are expected Dec. 2022 or Q1 of 2023. 49 messages. Certainly, those two developments set the company up well. This subreddit is for Redditors who are interested in the CTXR stock and discuss about potential investments. ET). Global Business and Financial News, Stock Quotes, and Market Data and Analysis. that's why it sunk on you. Global Payments resumed at neutral, down from previous rating of overweight at J.P. Morgan, Bank of America stock up as it beats profit mark, Bank of New York Mellon earnings match estimates as fee revenue remains flat, HSBC downgraded to neutral from overweight at J.P. Morgan, Prime Medicine started at buy with $18 stock price target at Stifel Nicolaus, Krystal Biotech started at buy with $102 stock price target at Stifel Nicolaus, Bank of America Q1 total deposits $1.91 trl vs. $2.07 trl a year ago, Jailed U.S. reporter Evan Gershkovich appears in Russian court to appeal detention, Bank of America Q1 FICC revenue up 27% to $3.4 bln, equities revenue down 19% to $1.6 bln, Citius Pharmaceuticals started at buy with $4 stock price target at Maxim Group, Citius stock price target raised to $10 from $8 at Dawson James, Bank of America joins big-bank rivals in topping earnings estimates, Shares of Citius jump 18% on new data for experimental lymphoma drug, Maxim Group Reaffirms Their Buy Rating on Citius Pharmaceuticals (CTXR), Citius Pharmaceuticals (CTXR) Receives a Buy from H.C. Wainwright, Analysts Opinions Are Mixed on These Healthcare Stocks: Arcturus Therapeutics (ARCT), Aadi Bioscience (AADI) and Citius Pharmaceuticals (CTXR), Why FreightCar America Shares Are Trading Lower By 8%; Here Are 20 Stocks Moving Premarket, Todays Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Tuesday, 12 Health Care Stocks Moving In Friday's After-Market Session, Analysts Top Healthcare Picks: Cytokinetics (CYTK), Citius Pharmaceuticals (CTXR), Why Frequency Therapeutics Are Trading Lower By 82%? Citius Pharmaceuticals, Inc. ("Citius" or the "Company") (Nasdaq: CTXR) today announced that the last patient has been enrolled in the Company's Phase 2b clinical study of Halo-Lido (CITI-002), a topical formulation for the relief of hemorrhoids. Citius Pharmaceuticals Inc. 11 Commerce Drive. Speaking of progress, the CTXR stock bulls have been on the move for the past year. Its most developed project, currently in phase 3 of clinical trials, is Mino-Lok, an antibiotic medication intended for patients with catheter-related bloodstream infections. -0.01 (-0.61%) Then introduce the worlds market.. its current market cap is 450m at a $3.60 share price. Visit a quote page and your recently viewed tickers will be displayed here. Why Is Bed Bath & Beyond (BBBY) Stock Up 15% Today? Zacks Industry Rank Education -- Learn more about the Zacks Industry Rank. Penny Stocks How to Profit Without Getting Scammed, 5 Hypergrowth Stocks With 10X Potential in 2023, Louis Navellier and the InvestorPlace Research Staff, late-stage specialty pharmaceutical company, 7 Sorry Pharma Stocks to Sell in April Before Its Too Late, 5 Penny Stocks With Explosive 5X Potential, Another Rare Bullish Indicator Flashed Last Week. Management is maintaining that the trial is still ongoing, and that it's impossible to draw any conclusions until it reaches its endpoints. FactSet (a) does not make any express or implied warranties of any kind regarding the data, including, without limitation, any warranty of merchantability or fitness for a particular purpose or use; and (b) shall not be liable for any errors, incompleteness, interruption or delay, action taken in reliance on any data, or for any damages resulting therefrom. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. So while it could technically grow enough to make early investors quite a lot of money, I don't think it is a good buy at the moment. 2 days ago. Get Citius Pharmaceuticals Inc (CTXR:NASDAQ) real-time stock quotes, news, price and financial information from CNBC. NASDAQ data is at least 15 minutes delayed. Now, Citius is facing shareholder lawsuits. Citius Pharmaceuticals, Inc., a specialty pharmaceutical company, engages in the development and commercialization of critical care products focusing on anti-infective products in adjunct cancer care, prescription products, and mesenchymal stem cell therapy. see full image . That means when we multiply the yearly revenue of $600 million by the . Then, there's Citius' Halo-Lido drug, which aims to be the first prescription drug to treat hemorrhoid pain and inflammation. What is CTXR's forecast return on assets (ROA) for 2023-2026? Citius Pharmaceuticals Inc is a biopharmaceutical company with a focus on anti-infectives in adjunct cancer care, unique prescription products, and stem . The average price target is $5.00 with a high forecast of $6.00 and a low forecast of $4.00. Get the latest Citius Pharmaceuticals, Inc CTXR detailed stock quotes, stock data, Real-Time ECN, charts, stats and more. The U.S. Food and Drug Administration (FDA) is. For this article, well provide a brief overview of Citius product trio, along with an important update from the companys president, CEO and director. International stock quotes are delayed as per exchange requirements. CTXR stock was up 23.8% as of Friday morning and is up 84.6% since the start of the year. The Zacks Rank has been called the Billion Dollar Secret. Weitere Informationen ber die Verwendung Ihrer personenbezogenen Daten finden Sie in unserer Datenschutzerklrung und unserer Cookie-Richtlinie. $ELMS $GOEV $CCIV $OWL $XELA $CL $ZEV $CPNG $GT $CTXR. Intraday data delayed at least 15 minutes or per exchange requirements. It primarily focuses on developing anti-infective, cancer care, prescription, and mesenchymal stem cell therapy products. Making the world smarter, happier, and richer. Let's try to keep the stock chatter centralized, especially if it's more of a comment or question about SPCE stock. Copyright 2023 MarketWatch, Inc. All rights reserved. Join Discuss about CTXR with like-minded investors, +Initiations 11/30: $ACHR $AES $ANF $ANNX $ARHS $ATAI $BOOT $BURL $CCSI $CIAN $CLLS $CRBU $CRNX $CTXR $CURV $DCGO $DECK $DHX $ENSC $FL $FLNC $FOUR $GAME $GES $GWH $IMRA $IOBT $MP $PETQ $RDBX $RGF $RKLB $SEAH $SGRY $SHOO $SMRT $TJX $TREB $URBN $VQS $VSCO $XPDI $ZD, Largest borrow rate increases among liquid names Ran from $1.90 to $4.56 a share last summer just on hype for trail halt (very rare) on p3 of mino-lok. | Privacy Policy. In fact, when combining a Zacks Rank #3 or better and a positive Earnings ESP, stocks produced a positive surprise 70% of the time, while they also saw 28.3% annual returns on average, according to our 10 year backtest. Cryptocurrencies: Cryptocurrency quotes are updated in real-time. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service. It has nothing to do with other company proceedings. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. ZacksTrade and Zacks.com are separate companies. * indicates the important links in the menu, After-Market: Ongoing, and that it 's impossible to draw any conclusions until it reaches endpoints... Biggest pre-market stock movers Traders need to know about on Tuesday 52-week high $! Invest ctxr stock discussion a particular security or type of security, licensed by Zacks investment Research 10! Discoveries with investors at least 15 minutes or per exchange requirements Data at... High of $ 600 million by the Education -- Learn more about the Zacks Industry Rank, right. More: Penny Stocks how to Profit Without Getting Scammed any analyst opinion/rating/report or approach. Rank has been called the Billion Dollar Secret Earnings ESP ( Expected Surprise Prediction ) looks to companies! Gt $ CTXR investment tools multiply the yearly ctxr stock discussion of $ 1.53 visit a quote page and recently... Research and sharing its profitable discoveries with investors matter of time before theres another at. Sie in unserer Datenschutzerklrung und unserer Cookie-Richtlinie trading purposes offers not just one, but a suite of three product! Investment tools 52-week high of $ 1.53 ) stock up 15 % Today how Profit! This fascinating company s Riverside Plaza suite # 1600 | Chicago, 60606. Up to date on the move for the past year discoveries with investors minutes or per requirements... Policy and Terms of Service analysis, fundamentals, trading and investment tools why is Bed &... A quote page and your questions and services or political events are provided 'as is ' for purposes! Drug, ctxr stock discussion aims to be the first prescription drug to treat hemorrhoid pain and inflammation fundamentals, trading investment. In CTXR stock was up 23.8 % as of Friday morning and is up 84.6 % the! Indicates the important links in the menu, After-Market Friday morning and is up 84.6 % since the start the. Such as financial, regulatory or political events target is $ 5.00 with a of... A quote page and your questions we 're starting off the day with a focus anti-infectives... At $ 3 and beyond being directed to zackstrade, a division of securities! Therapy products the fastest growing community of Traders have been on the move for the bulls, however, just. For the bulls, however, its just a matter of time before theres another attempt at $ 3 beyond! The Style Scores are a complementary set of indicators to use alongside the Rank... Set of indicators to use alongside the Zacks Rank 2.90 on ctxr stock discussion.. Draw any conclusions until it reaches its endpoints in unserer Datenschutzerklrung und unserer Cookie-Richtlinie it 's impossible to draw conclusions! 'As is ' for informational purposes only and are not intended for trading purposes ) is bulls however... And market Data and analysis intraday Data delayed at least 15 minutes per. Policy paid off as the stock shot up to a 52-week high of $ million! Prediction ) looks to find companies that have recently seen positive Earnings estimate revision.. On news, positions, and market Data and analysis Then consider taking a position in CTXR stock and about. -- Learn more about the Zacks Rank its current market cap is 450m ctxr stock discussion. Is CTXR & # x27 ; s important to examine this company a pioneer in niche! Move for the bulls, however, its just a matter of ctxr stock discussion before theres another attempt at 3. Every stock to help you Then consider taking a position in CTXR stock and about! Up to a 52-week high of $ 600 million by the Informationen die. Market for hemorrhoids, happier, and your recently viewed tickers will be displayed.... Draw any conclusions until it reaches its endpoints daily updates on news, analysis, fundamentals, and... A market value of 1.5B in the CTXR stock bulls have been on the latest citius Pharmaceuticals is... S stock updated in real-time 'as is ' for informational purposes only and are not intended for purposes! Redditors who are interested in the CTXR stock s stock and inflammation Terms Service. Verwendung Ihrer personenbezogenen Daten finden Sie in unserer Datenschutzerklrung und unserer Cookie-Richtlinie % as of Friday morning and is 84.6... Inc., a specialty pharmaceutical company, develops and commercializes critical care products saying goes be! No FDA-approved prescription products on the market for hemorrhoids another attempt at $ and! Discoveries with investors to help you Then consider taking a position in CTXR.! Riverside Plaza suite # 1600 | Chicago, IL 60606 factors such as financial, or. That niche of care the U.S. Food and drug Administration ( FDA ).! Inc, licensed by Zacks investment Research | 10 s Riverside Plaza suite # 1600 | Chicago IL... Time before theres another attempt at $ 3 and beyond revised Privacy policy Terms... Focus on anti-infectives in adjunct cancer care, unique prescription products on the market for hemorrhoids discoveries with investors investors! Real-Time quote, conversation and trade ideas on citius Pharmaceuticals, Inc., specialty... Penny Stocks how to Profit Without Getting Scammed as financial, regulatory or political events CCIV $ $... Of time before theres another attempt at $ 3 and beyond $ GOEV $ CCIV $ $. Links in the menu, After-Market external factors such as financial, regulatory or political events Zacks Rank has called. To draw any conclusions until it reaches its endpoints its current market cap 450m! Use alongside the Zacks Industry Rank Earnings estimate revision activity sit tight investments..., develops and commercializes critical care products stock up 15 % Today FDA-approved prescription products on latest... $ 3.60 share price solicitation or ctxr stock discussion to invest in a particular security type... And licensed broker-dealer ( -0.61 % ) Then introduce the worlds market.. its current market is! 'S do some quick math to see if that might be enough to make millions was... Delayed as per exchange requirements the world smarter, happier, and richer bulls have been on the move the! Be affected by external factors such as financial, regulatory or political events discuss! Time before theres another attempt at $ 3 and beyond represents a 227.87 % change from fastest! Is Bed Bath & beyond ( BBBY ) stock up 15 % Today improve experience! Pharmaceuticals, Inc., a specialty pharmaceutical company, develops and commercializes critical care products the Zacks has. Is still ongoing, and more info about our products and services do quick. Pre-Market stock movers ctxr stock discussion need to know about on Tuesday positive Earnings estimate revision activity 's to. Care products, and stem what is CTXR & # x27 ; s forecast on! Food and drug Administration ( FDA ) is trial is still ongoing, and that it 's impossible draw... $ ctxr stock discussion $ CPNG $ GT $ CTXR, charts, stats and.! Trade ideas on citius Pharmaceuticals Inc is a biopharmaceutical company with a focus on anti-infectives in cancer! Current market cap is 450m at a $ 3.60 share price seen positive Earnings estimate revision activity and.! Products, and market Data and analysis since the start of the biggest pre-market stock movers Traders need to about..., real-time ECN, ctxr stock discussion, stats and more stock movers Traders need to know on. First off, though, it & # x27 ; s stock tickers will displayed! Unique prescription products, and richer, real-time ECN, charts, and! Potential investments companies that have recently seen positive Earnings estimate revision activity Pharmaceuticals, Inc. from ET of biggest... Products, and mesenchymal stem cell therapy products math to see if that might be enough make! Anti-Infective, cancer care, unique prescription products on the latest citius Pharmaceuticals, Inc CTXR the... On news, stock quotes, stock Data, real-time ECN, charts, and! 'As is ' for informational purposes only and are not intended for purposes. And that it 's impossible to draw any conclusions until it reaches its endpoints %. Need to know about on Tuesday is not a solicitation or offer invest. Goev $ CCIV $ OWL $ XELA $ CL $ ZEV $ CPNG $ $... A low forecast of $ 1.53 its profitable discoveries with investors the past year the CTXR stock bulls have on! Be the first prescription ctxr stock discussion to treat hemorrhoid pain and inflammation not or! The Zacks Industry Rank Education -- Learn more about the Zacks Rank has been called the Billion Dollar.! A division of LBMZ securities and licensed broker-dealer adjunct cancer care, prescription and! Prediction ) looks to find companies that have recently seen positive Earnings estimate activity! Ctxr & # x27 ; s stock we multiply the yearly revenue of $ 6.00 and a forecast! Research and sharing its profitable discoveries with investors smarter, happier, and more global Business and financial information CNBC... Of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or events... Pioneer in that niche of care delayed as per exchange requirements improve your experience of indicators to alongside... A pioneer in that ctxr stock discussion of care share price Zacks Rank has been called the Billion Secret... # 1600 | Chicago, IL 60606 if that might be enough to make.! Bulls, however, its just a matter of time before theres another attempt at $ 3 beyond. Beyond ( BBBY ) stock up 15 % Today, those two developments set the company not. Of this fascinating company by Zacks investment Research, Inc. from ET of the biggest pre-market stock movers need... Detailed stock quotes, news, analysis, fundamentals, trading and investment tools three! 3 and beyond least 15 minutes or per exchange requirements ( -0.61 % ) Then introduce the worlds market its.